Veterans Affairs (VA) Signs Agreement with Theranica to Make Nerivio® Acute Migraine Therapeutic Device Available to Veterans
USA - English
News provided by
Share this article
Share this article
MONTCLAIR, N.J., Feb. 16, 2021 /PRNewswire/ Theranica, a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, today announced it has signed a Federal Supply Schedule (FSS) agreement with the United States Department of Veterans Affairs (VA), that will enable Veterans access to Nerivio®, a wearable for acute treatment of migraine. Nerivio has shown clinical efficacy for episodic and chronic migraine, both in clinical trials and real-world evidence analyses, said Jason Sico, MD, Associate Professor of Neurology and Internal Medicine in Yale School of Medicine. Providing headache care to both Veterans and non-Veterans, it has been my experience that Veterans tend to live with migraine and related headache disorder